AVMA news
NIH program in canine comparative oncology marks 20 years of progress
The National Institutes of Health created the Comparative Oncology Program two decades ago to advance the study of naturally occurring cancer in dogs,…
JAVMA news
Company takes canine cancer drug off market to study dosing
Oasmia Pharmaceutical AB has taken a canine cancer drug, Paccal Vet, or paclitaxel for injection, off the market to study lowering the
AVMA news
In Short - Jan. 15, 2022
Cornell receives $30 million toward its Canine Health Center and a survey delves into veterinarians' understanding and practice of oncology around the…
JAVMA news
FDA conditionally approves drug for treating lymphoma in dogs
The Food and Drug Administration announced Jan. 3 that it has conditionally approved Tanovea-CA1, or rabacfosadine, as the first animal drug to treat…
AVMA news
Four veterinary scientists recognized with AVMA research awards
The AVMA honored Drs. Jim E. Riviere, Nicholas (Nick) Jeffery, Natasha Olby, and Boaz Arzi with 2023 AVMA Excellence Awards for contributions to…
AVMA news
AVMA honors four veterinary scientists
The Association hailed Drs. Yrjö Gröhn, Stephen White, Stanley Marks, and Mike Nolan for promoting animal and human health through their notable…
JAVMA news
AVMA Animal Health Studies Database reaches 5 years, 500 listings
This June, the AVMA Animal Health Studies Database is marking the fifth anniversary of its launch. The AAHSD also recently surpassed 500 listings of…